The post-marketing drug-surveillance is mainly based upon spontaneous reporting, whereas in Italy there are a very little percentage of doctors who fill the ADR forms. To increase this percentage we activated an active reporting protocol in out ward. We limited the survey to NSAIDs to improve attention and the doctor's compliance. After an active training period the % of item filled was 95% and there was no differences after a 6 month interval. The % of ARD were 0.27% and 0.21% of DDD in the first and second period respectively.

Active reporting scheme: an example to evaluate specific adverse drug reactions / Pini, Luigi Alberto; Sternieri, E.. - In: ACTA PHYSIOLOGICA HUNGARICA. - ISSN 0231-424X. - STAMPA. - 75:(1990), pp. 237-238. (Intervento presentato al convegno 3 meeting tenutosi a Bologna nel 1-2 dicembre 1989).

Active reporting scheme: an example to evaluate specific adverse drug reactions.

PINI, Luigi Alberto;
1990

Abstract

The post-marketing drug-surveillance is mainly based upon spontaneous reporting, whereas in Italy there are a very little percentage of doctors who fill the ADR forms. To increase this percentage we activated an active reporting protocol in out ward. We limited the survey to NSAIDs to improve attention and the doctor's compliance. After an active training period the % of item filled was 95% and there was no differences after a 6 month interval. The % of ARD were 0.27% and 0.21% of DDD in the first and second period respectively.
1990
3 meeting
Bologna
1-2 dicembre 1989
75
237
238
Pini, Luigi Alberto; Sternieri, E.
Active reporting scheme: an example to evaluate specific adverse drug reactions / Pini, Luigi Alberto; Sternieri, E.. - In: ACTA PHYSIOLOGICA HUNGARICA. - ISSN 0231-424X. - STAMPA. - 75:(1990), pp. 237-238. (Intervento presentato al convegno 3 meeting tenutosi a Bologna nel 1-2 dicembre 1989).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/840101
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact